內房股普漲 百強房企4月銷售額同比年內首次轉正
格隆匯5月8日丨港股市場內房股普漲,其中,中駿集團、合景泰富和建發國際漲超4%,寶龍地產、融創中國、綠城中國、中國海外宏洋漲超3%,中國奧園、佳兆業集團、龍光地產、中國金茂、恆隆地產、中國恆大等漲超2%,世茂房地產漲近2%。上市房企4月銷售數據陸續披露,從公佈情況來看,4月樓市繼續回温,房企整體銷售規模環比大增。另據克而瑞數據統計,4月TOP100房企單月實現全口徑銷售金額9002.3億元,環比增17.2%,同比增0.6%,同比年內首次轉正。有研報稱,隨着各地房地產政策持續託底,疊加市場流動性趨於寬鬆,購房需求將逐漸上升,預計5月市場銷售情況將進一步改善。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.